ADIB O ABDOLKARIM
Allopathic & Osteopathic Physicians|Family Medicine WESTLAND, MI NPI 1578699807
Browse related groups: Allopathic & Osteopathic Physicians|Family Medicine MI GlaxoSmithKline, LLC. All categories
General Payments — all program years on this page
$4,533.67
- Category: General Payments
- Program years: PY2018–2024
- Record count: 158
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $269.27 across 9 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $269.27 | 9 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| GlaxoSmithKline, LLC. | $159.93 | 4 |
| Exact Sciences Corporation | $48.80 | 2 |
| UCB, Inc. | $22.28 | 1 |
| Indivior Inc. | $20.79 | 1 |
| Gilead Sciences, Inc. | $17.47 | 1 |
By program year
Records — PY2024 (9)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1114568065 | Exact Sciences Corporation | $24.23 | 10/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1114568069 | Exact Sciences Corporation | $24.57 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1116260698 | GlaxoSmithKline, LLC. | $20.05 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1116367867 | GlaxoSmithKline, LLC. | $124.74 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1116371695 | GlaxoSmithKline, LLC. | $1.62 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1116428532 | GlaxoSmithKline, LLC. | $13.52 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1133743185 | Gilead Sciences, Inc. | $17.47 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1143272964 | UCB, Inc. | $22.28 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1144522743 | Indivior Inc. | $20.79 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.